Qb Flu
Alternative Names: gH1-Qbeta; H1N1 influenza VLP vaccine - A*STAR/Cytos; Influenza A H1N1 virus-like particle vaccine - A*STAR/Cytos; Influenza-A virus vaccine - Cytos; Qb-Flu; Qb-VLP vaccine; Recombinant flu vaccine - A*STAR/CytosLatest Information Update: 27 Feb 2017
At a glance
- Originator Agency for Science, Technology and Research
- Developer Agency for Science, Technology and Research; Cytos Biotechnology; Singapore Immunology Network
- Class Influenza virus vaccines; Virus-like particle vaccines
- Mechanism of Action B cell stimulants; Helper-inducer T-lymphocyte modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Discontinued Influenza A virus H1N1 subtype
Most Recent Events
- 13 May 2014 Qb Flu is available for licensing as of 05 May 2014. http://www.cytos.com
- 05 May 2014 Suspended - Phase-I for Influenza-A virus H1N1 subtype in Singapore (Parenteral)
- 29 Jan 2014 Immunogenicity data from a phase I trial in Influenza-A virus H1N1 subtype (prevention, in volunteers) released by Cytos Biotechnology and Agency for Science, Technology and Research